KIAA0240 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.327600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.475600E-01
Normal-vs-Stage2
3.215800E-01
Normal-vs-Stage3
1.736190E-01
Normal-vs-Stage4
7.119600E-01
Stage1-vs-Stage2
1.433630E-01
Stage1-vs-Stage3
1.019740E-02
Stage1-vs-Stage4
5.390200E-01
Stage2-vs-Stage3
6.247600E-02
Stage2-vs-Stage4
4.342300E-02
Stage3-vs-Stage4
2.948100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.304800E-01
Normal-vs-AfricanAmerican
2.374800E-01
Normal-vs-Asian
9.234100E-02
Caucasian-vs-AfricanAmerican
5.176400E-01
Caucasian-vs-Asian
4.256800E-01
AfricanAmerican-vs-Asian
3.989000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.239400E-01
Normal-vs-Female
3.396200E-02
Male-vs-Female
5.975000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.877800E-01
Normal-vs-Age(41-60Yrs)
7.049800E-02
Normal-vs-Age(61-80Yrs)
3.095400E-01
Normal-vs-Age(81-100Yrs)
2.819200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.375400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.283200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.132400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.298200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.602980E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.138400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.618400E-02
Normal-vs-Daily Drinker
2.414200E-01
Normal-vs-Weekly Drinker
2.976400E-02
Normal-vs-Occasional Drinker
1.681760E-01
Normal-vs-Social Drinker
2.092600E-01
Non Drinker-vs-Daily Drinker
1.885180E-01
Non Drinker-vs-Weekly Drinker
4.917000E-01
Non Drinker-vs-Occasional Drinker
2.056200E-01
Non Drinker-vs-Social Drinker
2.875400E-01
Daily Drinker-vs-Weekly Drinker
6.775800E-01
Daily Drinker-vs-Occasional Drinker
2.123500E-02
Daily Drinker-vs-Social Drinker
4.506100E-02
Weekly Drinker-vs-Occasional Drinker
1.119580E-01
Weekly Drinker-vs-Social Drinker
1.723790E-01
Occasional Drinker-vs-Social Drinker
9.467000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.066400E-02
Normal-vs-Grade 2
2.542300E-02
Normal-vs-Grade 3
1.746150E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.461400E-01
Grade 1-vs-Grade 3
9.406800E-01
Grade 1-vs-Grade 4
6.066400E-02
Grade 2-vs-Grade 3
9.864800E-01
Grade 2-vs-Grade 4
2.542300E-02
Grade 3-vs-Grade 4
1.746150E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.015800E-01
Normal-vs-NonDiabetic
3.133600E-01
Diabetic-vs-NonDiabetic
7.426400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.474400E-01
Normal-vs-NoPancreatitis
3.244200E-01
Pancreatitis-vs-NoPancreatitis
1.922560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.121800E-02
Normal-vs-N1
3.274800E-01
N0-vs-N1
6.862200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.031600E-01
Normal-vs-TP53-NonMutant
5.307400E-01
TP53-Mutant-vs-TP53-NonMutant
8.091900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
